Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | LPO | P22079 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | FGB | P02675 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11384751 | 0.84 | KDM4E (0.40) | L3MBTL1KDM4ECYP2D6LPOMAPT | |
| SCHEMBL14148932 | 0.76 | L3MBTL1 (0.46) | L3MBTL1KDM4ECYP2D6LPOMAPT | |
| SCHEMBL4057810 | 0.76 | KDM4E (0.50) | L3MBTL1KDM4ECYP2D6LPOMAPT | |
| SCHEMBL950779 | 0.75 | KDM4E (0.44) | L3MBTL1KDM4ECYP2D6LPOMAPT | |
| SCHEMBL13663805 | 0.75 | L3MBTL1 (0.45) | L3MBTL1KDM4ECYP2D6LPOMAPT | |
| SCHEMBL8241575 | 0.75 | L3MBTL1 (0.45) | L3MBTL1KDM4ECYP2D6LPOMAPT | |
| SCHEMBL27942970 | 0.73 | L3MBTL1 (0.47) | L3MBTL1KDM4ECYP2D6LPOMAPT | |
| SCHEMBL27679740 | 0.73 | L3MBTL1 (0.47) | L3MBTL1KDM4ECYP2D6LPOMAPT | |
| SCHEMBL14665069 | 0.73 | KDM4E (0.51) | L3MBTL1KDM4ECYP2D6LPOMAPT | |
| Hydrochloric Acid SCHEMBL25338117 | 0.72 | L3MBTL1 (0.46) | L3MBTL1KDM4ECYP2D6LPOMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110021483-A1 | Platinum (IV) Complexes | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2011-01-27 | — | — | US | disclosed |
| EP-2170913-A1 | PLATINUM (IV) COMPLEXES | Platco Technologies (Proprietary) Limited (ZA) | 2010-04-07 | — | — | EP | disclosed |
| WO-2008155727-A1 | PLATINUM (IV) COMPLEXES | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2008-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021483-A1 | Platinum (IV) Complexes | OTC, OAT, SLC25A11 | L3MBTL1 2167/4885KDM4E 3423/4885CYP2D6 1078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.